{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:29:02Z","timestamp":1787232542326,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of D\u00fczce University","award":["2023.05.03.1407"],"award-info":[{"award-number":["2023.05.03.1407"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04840-5","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:06:29Z","timestamp":1781370389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and pharmacokinetic profiling of a novel pyrimidine imidazole based thiosemicarbazone derivative for BRAF inhibition in lung cancer therapy"],"prefix":"10.1007","volume":"17","author":[{"given":"Yavuz","family":"Ekincio\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamit Emre","family":"K\u0131z\u0131l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"G\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvan Hasano\u011flu","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Nartop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"8","key":"4840_CR1","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1016\/j.arabjc.2015.08.013","volume":"12","author":"MA Hussein","year":"2019","unstructured":"Hussein MA, Iqbal MA, Umar MI, Haque RA, Guan TS. Synthesis, structural elucidation and cytotoxicity of new thiosemicarbazone derivatives. Arab J Chem. 2019;12(8):3183\u201392.","journal-title":"Arab J Chem"},{"issue":"5","key":"4840_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.35333\/jrp.2020.222","volume":"24","author":"B Sever","year":"2020","unstructured":"Sever B, Akal\u0131n \u00c7ift\u00e7i G, \u00d6zdemir A, Alt\u0131ntop M. Design, synthesis and biological evaluation of new bis (thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer. J Res Pharm. 2020;24(5):670.","journal-title":"J Res Pharm"},{"issue":"1","key":"4840_CR3","first-page":"524701","volume":"2013","author":"W Hern\u00e1ndez","year":"2013","unstructured":"Hern\u00e1ndez W, Paz J, Carrasco F, Vaisberg A, Spodine E, Manzur J, et al. Synthesis and characterization of new palladium (II) thiosemicarbazone complexes and their cytotoxic activity against various human tumor cell lines. Bioinorg Chem Appl. 2013;2013(1):524701.","journal-title":"Bioinorg Chem Appl"},{"issue":"11","key":"4840_CR4","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/jm0512241","volume":"49","author":"L Otero","year":"2006","unstructured":"Otero L, Vieites M, Boiani L, Denicola A, Rigol C, Opazo L, et al. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J Med Chem. 2006;49(11):3322\u201331.","journal-title":"J Med Chem"},{"key":"4840_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bioorg.2017.07.002","volume":"75","author":"H Dong","year":"2017","unstructured":"Dong H, Liu J, Liu X, Yu Y, Cao S. Molecular docking and QSAR analyses of aromatic heterocycle thiosemicarbazone analogues for finding novel tyrosinase inhibitors. Bioorg Chem. 2017;75:106\u201317.","journal-title":"Bioorg Chem"},{"issue":"1","key":"4840_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0031-6865(99)00010-2","volume":"74","author":"S Pandeya","year":"1999","unstructured":"Pandeya S, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4 (3H)-one. Pharm Acta Helv. 1999;74(1):11\u20137.","journal-title":"Pharm Acta Helv"},{"key":"4840_CR7","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.rechem.2024.101328","volume":"7","author":"A Ghafoor","year":"2024","unstructured":"Ghafoor A, Hassan HR, Ismail M, Malik WMA, Afaq S, Nawaz H, et al. Synthesis, characterization and molecular docking studies of bioactive 1, 3-Thiazoles as promising antibacterial and antioxidant agents. Results Chem. 2024;7:101328.","journal-title":"Results Chem"},{"issue":"9","key":"4840_CR8","doi-asserted-by":"publisher","first-page":"e5736","DOI":"10.1002\/aoc.5736","volume":"34","author":"P Jain","year":"2020","unstructured":"Jain P, Sharma S, Kumar N, Misra N. Ni (II) and Cu (II) complexes of bidentate thiosemicarbazone ligand: Synthesis, structural, theoretical, biological studies and molecular modeling. Appl Organomet Chem. 2020;34(9):e5736.","journal-title":"Appl Organomet Chem"},{"issue":"3","key":"4840_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.bmcl.2015.12.049","volume":"26","author":"V Velezheva","year":"2016","unstructured":"Velezheva V, Brennan P, Ivanov P, Kornienko A, Lyubimov S, Kazarian K, et al. Synthesis and antituberculosis activity of indole\u2013pyridine derived hydrazides, hydrazide\u2013hydrazones, and thiosemicarbazones. Bioorg Med Chem Lett. 2016;26(3):978\u201385.","journal-title":"Bioorg Med Chem Lett"},{"issue":"40","key":"4840_CR10","doi-asserted-by":"publisher","first-page":"29308","DOI":"10.1039\/D4RA04002C","volume":"14","author":"D Nartop","year":"2024","unstructured":"Nartop D, \u00d6zkan EH, \u00d6\u011f\u00fctc\u00fc H, Yetim NK, \u00d6zdemir \u0130. Novel \u03b1-N-heterocyclic thiosemicarbazone complexes: synthesis, characterization, and antimicrobial of properties investigation. RSC Adv. 2024;14(40):29308\u201318.","journal-title":"RSC Adv"},{"issue":"10","key":"4840_CR11","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1080\/10406638.2023.2298863","volume":"44","author":"AZ Macit","year":"2024","unstructured":"Macit AZ, Hasano\u011flu \u00d6zkan E, Ogutcu H, Nartop D. Synthesis and in vitro antimicrobial evaluation of novel potent bioactive heterocyclic compounds. Polycycl Aromat Compd. 2024;44(10):6862\u201373.","journal-title":"Polycycl Aromat Compd"},{"issue":"1","key":"4840_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4274\/tpd.galenos.2024.93063","volume":"48","author":"F Bursal\u0131","year":"2024","unstructured":"Bursal\u0131 F, Demirkaya \u0130, Bircan \u0130B, \u015eim\u015fek FM. Larvicidal Activity of Some Aromatic Thiosemicarbazone and Metal Complexes [Ni (II), Cu (II), Co (II)] Against Aedes (Stegomyia) aegypti (Linnaeus, 1762) and Aedes albopictus (Skuse, 1894)(Diptera: Culicidae) Larvae. Turkiye Parazitol Derg. 2024;48(1):39\u201344.","journal-title":"Turkiye Parazitol Derg"},{"issue":"2","key":"4840_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1526-4998(200102)57:2<191::AID-PS275>3.0.CO;2-O","volume":"57","author":"M B\u00f6ger","year":"2001","unstructured":"B\u00f6ger M, D\u00fcrr D, Gsell L, Hall RG, Karrer F, Kristiansen O, et al. Synthesis and structure\u2013activity relationships of benzophenone hydrazone derivatives with insecticidal activity. Pest Manage Science: Former Pesticide Sci. 2001;57(2):191\u2013202.","journal-title":"Pest Manage Science: Former Pesticide Sci"},{"issue":"1","key":"4840_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/molecules30010129","volume":"30","author":"A Czylkowska","year":"2024","unstructured":"Czylkowska A, Pitucha M, Raducka A, Fornal E, Kordialik-Bogacka E, \u015acieszka S, et al. Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics. Molecules. 2024;30(1):129.","journal-title":"Molecules"},{"key":"4840_CR15","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s11164-013-1154-8","volume":"40","author":"B Xu","year":"2014","unstructured":"Xu B, Yu Y, Wan P, Wan C, Cao S. Synthesis and antityrosinase, antioxidant activities of phloretin thiosemicarbazones. Res Chem Intermed. 2014;40:3095\u2013107.","journal-title":"Res Chem Intermed"},{"issue":"4","key":"4840_CR16","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1155\/2011\/579892","volume":"8","author":"LN Suvarapu","year":"2011","unstructured":"Suvarapu LN, Reddy AV, Kumar GS, Baek SO. Spectral Characterization and Antibacterial Activities of Benzyloxybenzaldehydethiosemicarbazone, 3, 4-Dihydroxybenzaldehydeisonicotinoylhydrazone and their Transitional Metal Complexes. J Chem. 2011;8(4):1848\u201358.","journal-title":"J Chem"},{"issue":"12","key":"4840_CR17","doi-asserted-by":"publisher","first-page":"e2100580","DOI":"10.1002\/cbdv.202100580","volume":"18","author":"FZ Mohammed","year":"2021","unstructured":"Mohammed FZ, Rizzk YW, El Deen IM, Mourad AA, El Behery M. Design, synthesis, cytotoxic screening and molecular docking studies of novel hybrid thiosemicarbazone derivatives as anticancer agents. Chem Biodivers. 2021;18(12):e2100580.","journal-title":"Chem Biodivers"},{"issue":"5","key":"4840_CR18","doi-asserted-by":"publisher","first-page":"e7430","DOI":"10.1002\/aoc.7430","volume":"38","author":"AA Ali","year":"2024","unstructured":"Ali AA, Fouad R. Novel thiosemicarbazone complexes as anticancer agents: Synthesis, characterization, cytotoxicity, docking, and density functional theory studies. Appl Organomet Chem. 2024;38(5):e7430.","journal-title":"Appl Organomet Chem"},{"issue":"10","key":"4840_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1573406416666201021142832","volume":"17","author":"B Sever","year":"2021","unstructured":"Sever B, Alt\u0131ntop MD, \u00c7ift\u00e7i GA, \u00d6zdemir A. A new series of triazolothiadiazines as potential anticancer agents for targeted therapy of non-small cell lung and colorectal cancers: design, synthesis, in silico and in vitro studies providing mechanistic insight into their anticancer potencies. Med Chem. 2021;17(10):1104\u201328.","journal-title":"Med Chem"},{"key":"4840_CR20","doi-asserted-by":"publisher","first-page":"112142","DOI":"10.1016\/j.inoche.2024.112142","volume":"161","author":"RM Shrestha","year":"2024","unstructured":"Shrestha RM, Mahiya K, Shrestha A, Mohanty SR, Yadav SK, Yadav PN. Synthesis, characterization, and anticancer potency of coumarin-derived thiosemicarbazones and their Copper (II) complexes. Inorg Chem Commun. 2024;161:112142.","journal-title":"Inorg Chem Commun"},{"key":"4840_CR21","doi-asserted-by":"publisher","first-page":"141157","DOI":"10.1016\/j.molstruc.2024.141157","volume":"1327","author":"YR Pokharel","year":"2025","unstructured":"Pokharel YR, Singh NK, Sharma S, Wangchuk T, Shahi N, Mahiya K, et al. Synthesis, characterization, and in vitro anticancer activity of a series of N (4) dimethyl isatin thiosemicarbazones and their copper (II) complexes. J Mol Struct. 2025;1327:141157.","journal-title":"J Mol Struct"},{"issue":"9","key":"4840_CR22","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/molecules30092077","volume":"30","author":"O Garbuz","year":"2025","unstructured":"Garbuz O, Ceban E, Istrati D, Railean N, Toderas I, Gulea A. Thiosemicarbazone-Based Compounds: Cancer Cell Inhibitors with Antioxidant Properties. Molecules. 2025;30(9):2077.","journal-title":"Molecules"},{"issue":"3","key":"4840_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"4840_CR24","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348.","DOI":"10.3322\/caac.21763"},{"issue":"1","key":"4840_CR25","doi-asserted-by":"publisher","first-page":"33402","DOI":"10.1038\/s41598-025-18735-y","volume":"15","author":"H Aftab","year":"2025","unstructured":"Aftab H, Islam M, \u015eenol H, Batool Z, Ate\u015fo\u011flu \u015e, \u00c7ak\u0131r F, et al. Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones. Sci Rep. 2025;15(1):33402.","journal-title":"Sci Rep"},{"key":"4840_CR26","doi-asserted-by":"crossref","unstructured":"Duma N, Santana-Davila R, Molina JR. Non\u2013small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clinic Proceedings: Elsevier; 2019. pp. 1623-40.","DOI":"10.1016\/j.mayocp.2019.01.013"},{"issue":"11","key":"4840_CR27","first-page":"662","volume":"20","author":"P Abdayem","year":"2022","unstructured":"Abdayem P, Planchard D. Ongoing progress in BRAF-mutated non-small cell lung cancer. Clin Adv Hematol Oncol. 2022;20(11):662\u201372.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"4840_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target therapy. 2023;8(1):455.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"4840_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","volume":"14","author":"J Han","year":"2021","unstructured":"Han J, Liu Y, Yang S, Wu X, Li H, Wang Q. MEK inhibitors for the treatment of non-small cell lung cancer. J Hematol Oncol. 2021;14(1):1.","journal-title":"J Hematol Oncol"},{"key":"4840_CR30","doi-asserted-by":"publisher","first-page":"102335","DOI":"10.1016\/j.ctrv.2021.102335","volume":"103","author":"F Tabb\u00f2","year":"2022","unstructured":"Tabb\u00f2 F, Pisano C, Mazieres J, Mezquita L, Nadal E, Planchard D, et al. How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC). Cancer Treat Rev. 2022;103:102335.","journal-title":"Cancer Treat Rev"},{"issue":"24","key":"4840_CR31","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1158\/1078-0432.CCR-09-2074","volume":"15","author":"RK Amaravadi","year":"2009","unstructured":"Amaravadi RK, Schuchter LM, McDermott DF, Kramer A, Giles L, Gramlich K, et al. Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases. Clin Cancer Res. 2009;15(24):7711\u20138.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4840_CR32","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/ijms18071527","volume":"18","author":"XY Chan","year":"2017","unstructured":"Chan XY, Singh A, Osman N, Piva TJ. Role played by signalling pathways in overcoming BRAF inhibitor resistance in melanoma. Int J Mol Sci. 2017;18(7):1527.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4840_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11130-025-01304-z","volume":"80","author":"HE K\u0131z\u0131l","year":"2025","unstructured":"K\u0131z\u0131l HE, Ulcay S, Ekincio\u011flu Y, \u00d6\u011f\u00fct\u00e7\u00fc H, A\u011far G. An Integrated In Vitro and In Silico Investigation of the Bioactive Properties of Wild Glycyrrhiza glabra var. glandulifera. Plant Foods Hum Nutr. 2025;80(1):64.","journal-title":"Plant Foods Hum Nutr"},{"key":"4840_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2025.2520561","author":"\u0141J Walczak","year":"2025","unstructured":"Walczak \u0141J, Herbet M. Comparison of ADMET profile between thiosemicarbazide and semicarbazide derivatives regarding anticancer properties. Expert Opin Drug Metab Toxicol. 2025. https:\/\/doi.org\/10.1080\/17425255.2025.2520561.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4840_CR35","doi-asserted-by":"publisher","first-page":"136945","DOI":"10.1016\/j.molstruc.2023.136945","volume":"1299","author":"RM Shrestha","year":"2024","unstructured":"Shrestha RM, Mahiya K, Shrestha A, Mohanty SR, Yadav SK, Yadav PN. Synthesis, characterization, anticancer, pharmacokinetics and molecular docking investigation of N (3)-alkyl incorporated-3-acetyl-4-hydroxycoumarin thiosemicarbazones and their copper (II) complexes. J Mol Struct. 2024;1299:136945.","journal-title":"J Mol Struct"},{"issue":"1","key":"4840_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/154065804322966315","volume":"2","author":"TL Riss","year":"2004","unstructured":"Riss TL, Moravec RA. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol. 2004;2(1):51\u201362.","journal-title":"Assay Drug Dev Technol"},{"issue":"2","key":"4840_CR37","first-page":"105","volume":"2","author":"M Yildirim","year":"2022","unstructured":"Yildirim M, Aksakal E, Ozgeris FB, Ozgeris B, Gormez A. Biological Evaluation of Azide Derivative as Antibacterial and Anticancer Agents. Nat Prod Biotechnol. 2022;2(2):105\u201313.","journal-title":"Nat Prod Biotechnol"},{"issue":"5","key":"4840_CR38","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/cbin.11554","volume":"45","author":"N Barlak","year":"2021","unstructured":"Barlak N, Capik O, Kilic A, Sanli F, Aytatli A, Yazici A, et al. MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells. Cell Biol Int. 2021;45(5):1082\u201390.","journal-title":"Cell Biol Int"},{"key":"4840_CR39","unstructured":"Frisch M, Trucks G, Schlegel H, Scuseria G, Robb M, Cheeseman J et al. Gaussian 09, Revision D. 01, Gaussian, Inc., Wallingford CT. 2009. https:\/\/www.gaussian.com."},{"key":"4840_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.saa.2013.09.026","volume":"118","author":"X-H Li","year":"2014","unstructured":"Li X-H, Mei Z, Zhang X-Z. Computational study of the vibrational spectroscopic studies, natural bond orbital, frontier molecular orbital and second-order non-linear optical properties of acetophenone thiosemicarbazone molecule. Spectrochim Acta Part A Mol Biomol Spectrosc. 2014;118:543\u201351.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"4840_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molstruc.2017.09.056","volume":"1151","author":"F Ahmad","year":"2018","unstructured":"Ahmad F, Alam MJ, Alam M, Azaz S, Parveen M, Park S, et al. Synthesis, spectroscopic, computational (DFT\/B3LYP), AChE inhibition and antioxidant studies of imidazole derivative. J Mol Struct. 2018;1151:327\u201342.","journal-title":"J Mol Struct"},{"key":"4840_CR42","doi-asserted-by":"publisher","DOI":"10.4236\/ns.2012.45041","author":"M Mayaliwa","year":"2012","unstructured":"Mayaliwa M, Guido M, Okuma Emile K. Theoretical. DFT (B3LYP)\/6\u201331\u2009+\u2009G (d) study on the prediction of the preferred interaction site of 3-methyl-4-pyrimidone with different proton donors. Nat Sci. 2012. . https:\/\/doi.org\/10.4236\/ns.2012.45041","journal-title":"Nat Sci"},{"issue":"2","key":"4840_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"1","key":"4840_CR44","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"issue":"1","key":"4840_CR45","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.48048\/tis.2023.6403","volume":"20","author":"MS Sunkara","year":"2023","unstructured":"Sunkara MS, Kuchana V, Vemuri J, Bhowmik D. Ensemble pharmacophore meets molecular docking: A novel screening approach for the identification of B-Raf kinase inhibitors. Trends Sci. 2023;20(1):6403.","journal-title":"Trends Sci"},{"issue":"3","key":"4840_CR46","doi-asserted-by":"publisher","first-page":"e0193941","DOI":"10.1371\/journal.pone.0193941","volume":"13","author":"P Jabbarzadeh Kaboli","year":"2018","unstructured":"Jabbarzadeh Kaboli P, Ismail P, Ling K-H. Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment. PLoS ONE. 2018;13(3):e0193941.","journal-title":"PLoS ONE"},{"issue":"4","key":"4840_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s13538-021-00910-x","volume":"51","author":"Y Ekincio\u011flu","year":"2021","unstructured":"Ekincio\u011flu Y, K\u0131l\u0131\u00e7 H\u015e, Dereli \u00d6. DFT study of conformational analysis, molecular structure and properties of para-, meta-and ortho 4-methoxyphenyl piperazine isomers. Braz J Phys. 2021;51(4):958\u201368.","journal-title":"Braz J Phys"},{"issue":"5","key":"4840_CR48","doi-asserted-by":"publisher","first-page":"e1831637","DOI":"10.1080\/00268976.2020.1831637","volume":"119","author":"TM Gezhagn","year":"2021","unstructured":"Gezhagn TM, Temam AG, Lelisho TA. Theoretical study on chemical fixation of carbon dioxide with aziridine into cyclic carbamate catalysed by purine\/HI system. Mol Phys. 2021;119(5):e1831637.","journal-title":"Mol Phys"},{"key":"4840_CR49","unstructured":"Dennington R, Keith T, Millam J, GaussView V. Semichem Inc. Shawnee Mission KS. GaussView Version. 2009;5(8)."},{"issue":"5","key":"4840_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/1570180814666170704101817","volume":"15","author":"SV Tiwari","year":"2018","unstructured":"Tiwari SV, Nikalje AP, Lokwani DK, Sarkate AP, Jamir K. Synthesis, biological evaluation, molecular docking study and acute oral toxicity study of coupled imidazole-pyrimidine derivatives. Lett Drug Des Discovery. 2018;15(5):475\u201387.","journal-title":"Lett Drug Des Discovery"},{"issue":"24","key":"4840_CR51","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.1021\/acs.inorgchem.4c04871","volume":"64","author":"SK Yadav","year":"2025","unstructured":"Yadav SK, Kumar N, Sankar M. Oxidovanadium (IV) Porphyrin-Imidazole Complex-Catalyzed One-Pot, Three-Component Green Synthesis of Biologically Active Pyrano [2, 3-d] pyrimidine and 4 H-Chromene Heterocycles. Inorg Chem. 2025;64(24):11907\u201324.","journal-title":"Inorg Chem"},{"issue":"13","key":"4840_CR52","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1134\/S0036024423130241","volume":"97","author":"Y Ek\u00ednc\u00edo\u011flu","year":"2023","unstructured":"Ek\u00ednc\u00edo\u011flu Y. Theoretical investigation of (E)-1-(2, 4-dichlorophenyl)-3-[4-(morpholin-4-yl) phenyl] prop-2-en-1-one molecule as a possible potential COVID-19 drug candidate: Molecular docking and DFT calculations. Russ J Phys Chem A. 2023;97(13):3057\u201367.","journal-title":"Russ J Phys Chem A"},{"issue":"12","key":"4840_CR53","doi-asserted-by":"publisher","first-page":"2312425","DOI":"10.1002\/adfm.202312425","volume":"34","author":"A Badreldin","year":"2024","unstructured":"Badreldin A, Bouhali O, Abdel-Wahab A. Complimentary computational cues for water electrocatalysis: A DFT and ML perspective. Adv Funct Mater. 2024;34(12):2312425.","journal-title":"Adv Funct Mater"},{"issue":"7","key":"4840_CR54","first-page":"7424","volume":"9","author":"KM Potla","year":"2024","unstructured":"Potla KM, Nuthalapati P, Sasi Mohan JT, Os\u00f3rio FA, Valverde C, Vankayalapati S, et al. Multifaceted Study of a Y-Shaped Pyrimidine Compound: Assessing Structural Properties, Docking Interactions, and Third-Order Nonlinear Optics. ACS omega. 2024;9(7):7424\u201338.","journal-title":"ACS omega"},{"issue":"10","key":"4840_CR55","doi-asserted-by":"publisher","first-page":"o3408","DOI":"10.1107\/S1600536805030059","volume":"61","author":"L-X Xu","year":"2005","unstructured":"Xu L-X, Yu G-P, Si G-D, Shang Y-Q, Li W-H, Hou B-R. 4-(4-Chlorobenzylideneamino)-3-(1H-1, 2, 4-triazol-1-ylmethyl)-1H-1, 2, 4-triazole-5 (4H)-thione. Acta Crystallogr Sect E: Struct Rep Online. 2005;61(10):o3408\u20139.","journal-title":"Acta Crystallogr Sect E: Struct Rep Online"},{"issue":"1\u20136","key":"4840_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0031-8914(34)90011-2","volume":"1","author":"T Koopmans","year":"1934","unstructured":"Koopmans T. About the assignment of wave functions and eigenvalues to the individual electrons of an atom. Physica. 1934;1(1\u20136):104\u201313.","journal-title":"Physica"},{"issue":"9","key":"4840_CR57","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/ja983494x","volume":"121","author":"RG Parr","year":"1999","unstructured":"Parr RG, Szentp\u00e1ly Lv, Liu S. Electrophilicity index. J Am Chem Soc. 1999;121(9):1922\u20134.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"4840_CR58","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1021\/ic00277a030","volume":"27","author":"RG Pearson","year":"1988","unstructured":"Pearson RG. Absolute electronegativity and hardness: application to inorganic chemistry. Inorg Chem. 1988;27(4):734\u201340.","journal-title":"Inorg Chem"},{"issue":"2","key":"4840_CR59","first-page":"153","volume":"1","author":"JS Murray","year":"2011","unstructured":"Murray JS, Politzer P. The electrostatic potential: an overview. Wiley Interdisciplinary Reviews: Comput Mol Sci. 2011;1(2):153\u201363.","journal-title":"Wiley Interdisciplinary Reviews: Comput Mol Sci"},{"key":"4840_CR60","unstructured":"Biovia DS. Discovery studio modeling environment. Release San Diego; 2017."},{"issue":"1","key":"4840_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bioinformatics\/btp599","volume":"26","author":"J Yu","year":"2010","unstructured":"Yu J, Zhou Y, Tanaka I, Yao M. Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere. Bioinformatics. 2010;26(1):46\u201352.","journal-title":"Bioinformatics"},{"key":"4840_CR62","doi-asserted-by":"publisher","first-page":"141346","DOI":"10.1016\/j.molstruc.2025.141346","volume":"1329","author":"A Yadav","year":"2025","unstructured":"Yadav A, Singh VK, Kumar R, Yadav V, Kushwaha AK, Rana VK, et al. Regioselective sulfenylation of indoles using sulfonyl hydrazides: In silico design, DFT calculation, hirshfeld surface analysis, ADMET study, molecular docking and anticancer activity. J Mol Struct. 2025;1329:141346.","journal-title":"J Mol Struct"},{"key":"4840_CR63","doi-asserted-by":"crossref","unstructured":"Khaoua O. Reactivity, bioactivity, and antileishmanial activity of dihydrosyrindine and syringine: Modelling, cytotoxicity, molecular docking, molecular dynamics, and MM-GBSA analyses. J Mol Graph Model. 2025:109183.","DOI":"10.1016\/j.jmgm.2025.109183"},{"key":"4840_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4\u201317.","journal-title":"Adv Drug Deliv Rev"},{"issue":"21","key":"4840_CR65","doi-asserted-by":"publisher","first-page":"14261","DOI":"10.1021\/acs.jmedchem.2c01147","volume":"65","author":"PW Kenny","year":"2022","unstructured":"Kenny PW. Hydrogen-bond donors in drug design. J Med Chem. 2022;65(21):14261\u201375.","journal-title":"J Med Chem"},{"issue":"3","key":"4840_CR66","first-page":"244","volume":"2","author":"JM S\u00e1nchez-Torres","year":"2013","unstructured":"S\u00e1nchez-Torres JM, Viteri S, Molina MA, Rosell R. BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors. Translational lung cancer Res. 2013;2(3):244.","journal-title":"Translational lung cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04840-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:02:41Z","timestamp":1787230961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04840-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable for studies not involving humans or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1218"}}